| PERIOD ENDING | 31-Aug-09 | 31-May-09 | 28-Feb-09 | 30-Nov-08 | | Total Revenue | 32,347 | 30,890 | 27,839 | 31,187 | | Cost of Revenue | 15,077 | 15,413 | 14,812 | 15,062 | | | Gross Profit | 17,270 | 15,477 | 13,027 | 16,125 | | | Operating Expenses | | Research Development | 1,464 | 1,119 | 1,265 | 1,219 | | Selling General and Administrative | 8,862 | 8,955 | 8,191 | 9,045 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 6,944 | 5,403 | 3,571 | 5,861 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 51 | 89 | 602 | 240 | | Earnings Before Interest And Taxes | 6,995 | 5,492 | 4,173 | 6,101 | | Interest Expense |
-
|
-
|
-
|
-
| | Income Before Tax | 6,995 | 5,492 | 4,173 | 6,101 | | Income Tax Expense | 2,600 | 2,075 | 1,350 | 2,200 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 4,395 | 3,417 | 2,823 | 3,901 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 4,395 | 3,417 | 2,823 | 3,901 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $4,395 | $3,417 | $2,823 | $3,901 |
|
0.51% Nasdaq 
Income Statement
